Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: a case report

Arch Gynecol Obstet. 2009 Jan;279(1):57-60. doi: 10.1007/s00404-008-0631-6. Epub 2008 Apr 1.

Abstract

Background: Approximately 50% of patients with low-grade endometrial stromal sarcoma (ESS) develop recurrent disease including mainly metastases of pelvis and lung. A solitary pulmonary metastasis of this disease is a rare phenomenon.

Case: After initial surgical treatment in 1990, a 28-year-old female developed solitary metastases of the lung in 1998 and 1999, which were surgically removed both times. The patient was then treated with goserelin for 2 years followed by anastrozole to date. She has since been disease-free.

Conclusions: This case report emphasizes the importance of long-term follow-up and initial surgical treatment of low-grade ESS and suggests systemic hormonal therapy in case of recurrence.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anastrozole
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Combined Modality Therapy
  • Disease-Free Survival
  • Endometrial Neoplasms / drug therapy*
  • Endometrial Neoplasms / pathology
  • Endometrial Neoplasms / surgery
  • Female
  • Goserelin / therapeutic use
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / secondary
  • Lung Neoplasms / surgery
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / pathology
  • Nitriles / therapeutic use
  • Sarcoma, Endometrial Stromal / drug therapy*
  • Sarcoma, Endometrial Stromal / secondary
  • Sarcoma, Endometrial Stromal / surgery
  • Triazoles / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Nitriles
  • Triazoles
  • Goserelin
  • Anastrozole